{
  "id": 1769622344969,
  "seqId": 169,
  "title": "Viral & Chlamydial Conjunctivitis: The Complete Clinical Compendium",
  "summary": "An exhaustive guide to identifying and managing viral and chlamydial infections of the conjunctiva. This poster covers everything from Adenoviral serotypes and Keratitis stages to the WHO Trachoma classification and SAFE strategy.",
  "date": "2026-01-28T17:45:44.969Z",
  "data": {
    "title": "Viral & Chlamydial Conjunctivitis: The Complete Clinical Compendium",
    "summary": "An exhaustive guide to identifying and managing viral and chlamydial infections of the conjunctiva. This poster covers everything from Adenoviral serotypes and Keratitis stages to the WHO Trachoma classification and SAFE strategy.",
    "summary_illustration": "<svg viewBox='0 0 100 100' xmlns='http://www.w3.org/2000/svg'><circle cx='50' cy='50' r='40' fill='none' stroke='hsl(215, 90%, 45%)' stroke-width='2'/><path d='M30 50 Q50 20 70 50 Q50 80 30 50' fill='none' stroke='hsl(215, 90%, 45%)' stroke-width='2'/><circle cx='50' cy='50' r='8' fill='hsl(215, 90%, 45%)'/><circle cx='80' cy='20' r='5' fill='hsl(0, 70%, 50%)'/><circle cx='85' cy='35' r='3' fill='hsl(120, 60%, 40%)'/><path d='M75 15 L85 25 M85 15 L75 25' stroke='hsl(0, 70%, 50%)' stroke-width='1'/></svg>",
    "sections": [
      {
        "title": "Adenovirus: Viral Profile",
        "icon": "microbiology",
        "type": "mindmap",
        "layout": "full_width",
        "color_theme": "blue",
        "content": {
          "center": "Adenovirus (dsDNA)",
          "branches": [
            "Over 40 serotypes identified",
            "Incubation period: 71wk",
            "Highly contagious",
            "Virus shedding: Continues for a further 2wk"
          ]
        }
      },
      {
        "title": "Adenoviral Syndromes: PCF vs EKC",
        "icon": "compare",
        "type": "table",
        "layout": "full_width",
        "color_theme": "purple",
        "content": {
          "headers": [
            "Feature",
            "Pharyngoconjunctival Fever (PCF)",
            "Epidemic Keratoconjunctivitis (EKC)"
          ],
          "rows": [
            [
              "Serotypes",
              "3, 7, and many others",
              "8, 19, and 37"
            ],
            [
              "Transmission",
              "Aerosol transmission",
              "Contact (fingers, instruments)"
            ],
            [
              "Demographics",
              "Common in children/young adults",
              "Epidemics: Nosocomial (eye clinics/casualty) or generalized"
            ],
            [
              "Systemic Upset",
              "Common (typically upper respiratory tract infection)",
              "Rare"
            ],
            [
              "Keratitis",
              "Up to 30%; usually mild",
              "Up to 80%; can be severe"
            ]
          ]
        }
      },
      {
        "title": "Adenoviral Clinical Features",
        "icon": "visibility",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "blue",
        "content": [
          "Acute onset (7–10d)",
          "Symptoms: Watering, burning, itching ± photophobia/blurred vision (if keratitis)",
          "Watery discharge & lid oedema",
          "Moderate chemosis",
          "Follicles: Inferior > superior",
          "Tender preauricular lymphadenopathy",
          "± Subconjunctival petechial haemorrhage",
          "± Pseudomembrane",
          "± Symblepharon",
          "Keratitis"
        ]
      },
      {
        "title": "The Three Stages of Keratitis",
        "icon": "layers",
        "type": "process",
        "layout": "half_width",
        "color_theme": "blue",
        "content": [
          "Stage 1 (d1–7): Diffuse epithelial keratitis (fluorescein staining)",
          "Stage 2 (d7–30): Focal epithelial keratitis (fluorescein staining)",
          "Stage 3 (d11 onwards): Subepithelial opacities (may last years; non-staining)"
        ]
      },
      {
        "title": "Adenoviral Management",
        "icon": "medical_services",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "green",
        "content": [
          "Investigation: Conjunctival swabs (viral transport medium) for viral antigen determination or PCR",
          "Supportive: Cool compresses and artificial tears",
          "Antibiotics: ± Topical antibiotics (supposedly to prevent 2° bacterial infection)",
          "Steroids: Some authors advocate low-dose topical steroids if subepithelial opacities affect vision",
          "Steroid Risk: Opacities recur on cessation; encourages long-term steroid dependency"
        ]
      },
      {
        "title": "Spread Prevention Protocol",
        "icon": "clean_hands",
        "type": "red_flag",
        "layout": "half_width",
        "color_theme": "red",
        "content": [
          "Wash hands and clean equipment before the next patient",
          "Advise: Frequent handwashing",
          "Advise: Minimal touching of eyes",
          "Advise: Not sharing towels/flannels",
          "Advise: Not shaking hands",
          "Follow-up if condition worsens or persists after treatment"
        ]
      },
      {
        "title": "Molluscum Contagiosum",
        "icon": "coronavirus",
        "type": "plain_text",
        "layout": "half_width",
        "color_theme": "purple",
        "content": "This dsDNA virus of the pox virus group is common in children/young adults; profuse lesions are seen with HIV infection or severe immunosuppression. Transmission is by close contact. The lesions may be missed if buried in the lash margin. Shedding of viral particles from the lesion may cause persistent follicular conjunctivitis.\n\nClinical features: Chronic history; pearly, umbilicated nodule at lid margin; mucoid discharge; follicles.\n\nTreatment: Remove the lid lesion (e.g. cryotherapy, cauterization, shave excision, expression)."
      },
      {
        "title": "Herpes Simplex (Type 1)",
        "icon": "vaccines",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "blue",
        "content": [
          "Blepharokeratoconjunctivitis: Usually a 1° infection of this dsDNA virus",
          "Clinical Features: Burning, FB sensation; unilateral follicular conjunctivitis",
          "Preauricular lymphadenopathy",
          "± Lid vesicles ± Keratitis (e.g. dendritic ulcer)",
          "Topical Treatment: Aciclovir 3% Oc 5×/d for 3wk",
          "BNF Recommendation: Treat until 3d after complete healing",
          "If keratitis: Treat accordingly (refer to pp. 258–9/262–3)"
        ]
      },
      {
        "title": "Other Viral Causes",
        "icon": "list",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "blue",
        "content": [
          "Other members of the herpes group",
          "Enterovirus 70",
          "Coxsackie A24",
          "Influenza A",
          "Newcastle disease virus"
        ]
      },
      {
        "title": "Chlamydial Conjunctivitis: Biology",
        "icon": "biotech",
        "type": "mindmap",
        "layout": "half_width",
        "color_theme": "green",
        "content": {
          "center": "Chlamydiae (Gram-negative)",
          "branches": [
            "Elementary body: Spore-like infectious particle",
            "Reticular body: Obligate intracellular reproductive stage",
            "Replicates within host cell (seen as inclusion body)"
          ]
        }
      },
      {
        "title": "Adult Inclusion Conjunctivitis",
        "icon": "group",
        "type": "key_point",
        "layout": "full_width",
        "color_theme": "green",
        "content": [
          "Pathogen: C. trachomatis serotypes D–K",
          "Transmission: Almost always sexually transmitted (occasional eye-to-eye)",
          "Demographics: Most common in young adults (♂ > ♀)",
          "Onset: Subacute (2–3wk)",
          "Laterality: Usually unilateral (but may be bilateral)",
          "Signs: Mucopurulent discharge, lid oedema ± ptosis, follicles (papillae initially)",
          "Lymphadenopathy: Non-tender",
          "Superior pannus: Late sign",
          "Localization: Usually most severe on superior tarsus and bulbar conjunctiva",
          "Keratitis: Punctate epithelial erosions, subepithelial opacities, marginal infiltrates",
          "Systemic (often asymptomatic): Cervicitis (♀), urethritis (♂)"
        ]
      },
      {
        "title": "Inclusion Conjunctivitis: Management",
        "icon": "assignment_turned_in",
        "type": "process",
        "layout": "half_width",
        "color_theme": "green",
        "content": [
          "Investigation: Firmly swab superior tarsus for immunofluorescent staining, culture, PCR, or ELISA",
          "Referral: Refer to GU clinic for assessment, treatment, and contact tracing",
          "First line Topical: Chloramphenicol Oc 1% 4×/d (bacteriostatic)",
          "First line Systemic: Azithromycin 1g stat OR Doxycycline 100mg 2×/d for 1wk",
          "Pregnancy protocol: Erythromycin (e.g. 500mg 2×/d for 2wk)"
        ]
      },
      {
        "title": "Trachoma & Global Impact",
        "icon": "public",
        "type": "mindmap",
        "layout": "half_width",
        "color_theme": "yellow",
        "content": {
          "center": "Trachoma",
          "branches": [
            "10–15% of global blindness",
            "Leading preventable cause",
            "C. trachomatis serotypes A, B, Ba, and C",
            "Vector: Common fly",
            "Risk: Crowding and poor hygiene"
          ]
        }
      },
      {
        "title": "WHO Classification of Trachoma",
        "icon": "grid_view",
        "type": "table",
        "layout": "full_width",
        "color_theme": "yellow",
        "content": {
          "headers": [
            "Code",
            "Grade",
            "Definition"
          ],
          "rows": [
            [
              "TF",
              "Trachomatous inflammation: follicular",
              ">5 follicles on upper tarsus"
            ],
            [
              "TI",
              "Trachomatous inflammation: intense",
              "Tarsal inflammation sufficient to obscure >50% of tarsal vessels"
            ],
            [
              "TS",
              "Trachomatous scarring",
              "Conjunctival scarring"
            ],
            [
              "TT",
              "Trachomatous trichiasis",
              "Trichiasis"
            ],
            [
              "CO",
              "Corneal opacity",
              "Corneal opacity involving at least part of the pupillary margin"
            ]
          ]
        }
      },
      {
        "title": "The SAFE Strategy",
        "icon": "shield",
        "type": "remember",
        "layout": "half_width",
        "color_theme": "green",
        "content": {
          "mnemonic": "SAFE",
          "explanation": "S: Surgery (for in-turned eyelashes), A: Antibiotics (for active disease), F: Face washing (promotion of facial cleanliness), E: Environmental improvement (to reduce transmission)"
        }
      },
      {
        "title": "Trachoma Clinical Features",
        "icon": "history_edu",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "yellow",
        "content": [
          "Follicular reaction: More marked in upper rather than lower lid",
          "Arlt lines: On the superior tarsus (scarring)",
          "Trichiasis, Entropion, Dry eyes",
          "Herbert pits: Limbal follicles that have scarred",
          "Keratitis: Superficial, subepithelial, ulceration",
          "Microbial keratitis: 2° infection risk",
          "Pannus formation"
        ]
      },
      {
        "title": "Trachoma Investigation & Treatment",
        "icon": "medication",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "green",
        "content": [
          "Acute Investigations: Swabs for immunofluorescent staining, culture, PCR, or ELISA",
          "Medical Treatment: Azithromycin 1g PO stat",
          "Symptomatic Relief: Ocular lubricants",
          "Surgical: Correction of lid/lashes position"
        ]
      },
      {
        "title": "Note on Neonatal Infections",
        "icon": "baby_changing_station",
        "type": "plain_text",
        "layout": "half_width",
        "color_theme": "blue",
        "content": "For Neonatal chlamydial conjunctivitis, see E Ophthalmia neonatorum, pp. 882–3. WHO aims to eliminate trachoma as a blinding disease by 2020."
      }
    ],
    "chapterId": "conjunctiva"
  },
  "chapterId": "conjunctiva",
  "_newlyImported": 1769622344969,
  "communityId": "sub_1769618268159_wmn82zwmvi1z3t",
  "communityAuthor": "Dodiii",
  "communityDate": "2026-01-28T16:37:48.159Z"
}